Anti-calcitonin gene-related peptide monoclonal antibodies are the first approved pharmacologic treatments developed explicitly for the prevention of migraine.
Amy L. Dix, MPAS, PA-C, AQH, MSCS
Amy L. Dix, MPAS, PA-C, AQH, MSCS, is a PhD student at the University of NOVA Southeastern, Dr. Pallavi Patel College of Health Sciences. She is currently employed by EMD Serono, Inc.
